Immunophenotypic characteristics of brain metastases
Up to 15% of patients with secondary brain tumors of unknown primary are admitted to a neurosurgery department. Identification of a primary tumor site on the basis of surgical material immunophenotyping in routine clinical practice has a significant potential; however, this requires systematization....
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2018-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/998 |
| _version_ | 1827062824218656768 |
|---|---|
| author | G. A. Demyashkin E. A. Shalamova P. V. Nikitin S. N. Bogomolov |
| author_facet | G. A. Demyashkin E. A. Shalamova P. V. Nikitin S. N. Bogomolov |
| author_sort | G. A. Demyashkin |
| collection | DOAJ |
| description | Up to 15% of patients with secondary brain tumors of unknown primary are admitted to a neurosurgery department. Identification of a primary tumor site on the basis of surgical material immunophenotyping in routine clinical practice has a significant potential; however, this requires systematization.Objective: to detect the primary focus of brain carcinoma. Patients and methods.Surgical specimens from 7 patients with brain tumor of unknown primary were investigated using light optical microscopy and an immunohistochemical (IHC) panel including EMA, CK AE1/3, CK7, CK5/6, GFAP, S-100, Vimentin, p63, TTF-1, Uroplakin III (UPIII), CDX2, and Her2/neu.Results and discussion. A study using the IHC panel made it possible to obtain the following tumor phenotypes in the patients: CK5/6+, p63+, CK7+, UPIII+ (urothelial cancer) (n=3); CK5/6-, CK7+, TTF-1+, CDX2- (lung adenocarcinoma) (n=2); CK5/6+, p63+, CK7-, UPIII, TTF-1- (squamous cell carcinoma) (n=1), and CK5/6-, CK7+, TTF-1-, CDX2-, Her2/neu+ (breast cancer) (n=1). Evidence of the primary focus of the tumors was subsequently confirmed by instrumental techniques in all cases when cancer of the breast, lung and urinary system was directly sought. The findings were used to elaborate an algorithm for the differential diagnostic immunophenotyping of brain metastases.Conclusion. The primary focus of brain carcinoma was detected in all cases on the proposed IHC panel. The systematized algorithm for differential diagnostic immunophenotyping can be used in clinical practice. |
| first_indexed | 2024-04-10T02:01:37Z |
| format | Article |
| id | doaj.art-0ec0bbf2087c44fb95d428ce88680fd6 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:02:01Z |
| publishDate | 2018-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-0ec0bbf2087c44fb95d428ce88680fd62024-10-17T16:15:25ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422018-12-01104596410.14412/2074-2711-2018-4-59-64801Immunophenotypic characteristics of brain metastasesG. A. Demyashkin0E. A. Shalamova1P. V. Nikitin2S. N. Bogomolov3Medical Diagnostic Center Nine, Ministry of Defense of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaAcad. N.N. Burdenko National Research and Practical Center for Neurosurgery, Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaUp to 15% of patients with secondary brain tumors of unknown primary are admitted to a neurosurgery department. Identification of a primary tumor site on the basis of surgical material immunophenotyping in routine clinical practice has a significant potential; however, this requires systematization.Objective: to detect the primary focus of brain carcinoma. Patients and methods.Surgical specimens from 7 patients with brain tumor of unknown primary were investigated using light optical microscopy and an immunohistochemical (IHC) panel including EMA, CK AE1/3, CK7, CK5/6, GFAP, S-100, Vimentin, p63, TTF-1, Uroplakin III (UPIII), CDX2, and Her2/neu.Results and discussion. A study using the IHC panel made it possible to obtain the following tumor phenotypes in the patients: CK5/6+, p63+, CK7+, UPIII+ (urothelial cancer) (n=3); CK5/6-, CK7+, TTF-1+, CDX2- (lung adenocarcinoma) (n=2); CK5/6+, p63+, CK7-, UPIII, TTF-1- (squamous cell carcinoma) (n=1), and CK5/6-, CK7+, TTF-1-, CDX2-, Her2/neu+ (breast cancer) (n=1). Evidence of the primary focus of the tumors was subsequently confirmed by instrumental techniques in all cases when cancer of the breast, lung and urinary system was directly sought. The findings were used to elaborate an algorithm for the differential diagnostic immunophenotyping of brain metastases.Conclusion. The primary focus of brain carcinoma was detected in all cases on the proposed IHC panel. The systematized algorithm for differential diagnostic immunophenotyping can be used in clinical practice.https://nnp.ima-press.net/nnp/article/view/998metastases of unknown primarysecondary tumorbrainimmunophenotyping |
| spellingShingle | G. A. Demyashkin E. A. Shalamova P. V. Nikitin S. N. Bogomolov Immunophenotypic characteristics of brain metastases Неврология, нейропсихиатрия, психосоматика metastases of unknown primary secondary tumor brain immunophenotyping |
| title | Immunophenotypic characteristics of brain metastases |
| title_full | Immunophenotypic characteristics of brain metastases |
| title_fullStr | Immunophenotypic characteristics of brain metastases |
| title_full_unstemmed | Immunophenotypic characteristics of brain metastases |
| title_short | Immunophenotypic characteristics of brain metastases |
| title_sort | immunophenotypic characteristics of brain metastases |
| topic | metastases of unknown primary secondary tumor brain immunophenotyping |
| url | https://nnp.ima-press.net/nnp/article/view/998 |
| work_keys_str_mv | AT gademyashkin immunophenotypiccharacteristicsofbrainmetastases AT eashalamova immunophenotypiccharacteristicsofbrainmetastases AT pvnikitin immunophenotypiccharacteristicsofbrainmetastases AT snbogomolov immunophenotypiccharacteristicsofbrainmetastases |